These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prevalence and epidemiological associates of novel psychedelic use in the United States adult population. Sexton JD; Crawford MS; Sweat NW; Varley A; Green EE; Hendricks PS J Psychopharmacol; 2019 Sep; 33(9):1058-1067. PubMed ID: 30816808 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom. Simonsson O; Hendricks PS; Stenfors CU; Goldberg SB; Honk L; Osika W J Psychopharmacol; 2024 Jan; 38(1):110-115. PubMed ID: 38140891 [TBL] [Abstract][Full Text] [Related]
8. Associations between lifetime classic psychedelic use and markers of physical health. Simonsson O; Sexton JD; Hendricks PS J Psychopharmacol; 2021 Apr; 35(4):447-452. PubMed ID: 33719688 [TBL] [Abstract][Full Text] [Related]
9. Classic Psychedelics and Human-Animal Relations. Pöllänen E; Osika W; Stenfors CUD; Simonsson O Int J Environ Res Public Health; 2022 Jul; 19(13):. PubMed ID: 35805769 [TBL] [Abstract][Full Text] [Related]
10. Classic psychedelic use and current meditation practice. Simonsson C; Chambers R; Hendricks PS; Goldberg SB; Osika W; Schlosser M; Ryde A; Christersson E; Simonsson O Mindfulness (N Y); 2023 Apr; 14(4):763-768. PubMed ID: 37693239 [TBL] [Abstract][Full Text] [Related]
11. Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample. Mellner C; Dahlen M; Simonsson O Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141631 [TBL] [Abstract][Full Text] [Related]
12. Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States. Simonsson O; Goldberg SB J Psychoactive Drugs; 2023; 55(1):11-18. PubMed ID: 35000559 [TBL] [Abstract][Full Text] [Related]
13. Are you tripping comfortably? Investigating the relationship between harm reduction and the psychedelic experience. Palmer M; Maynard OM Harm Reduct J; 2022 Jul; 19(1):81. PubMed ID: 35871679 [TBL] [Abstract][Full Text] [Related]
14. Cessation and reduction in alcohol consumption and misuse after psychedelic use. Garcia-Romeu A; Davis AK; Erowid F; Erowid E; Griffiths RR; Johnson MW J Psychopharmacol; 2019 Sep; 33(9):1088-1101. PubMed ID: 31084460 [TBL] [Abstract][Full Text] [Related]
15. The use of classic psychedelics among adults: a Danish online survey study. Søgaard Juul T; Ebbesen Jensen M; Fink-Jensen A Nord J Psychiatry; 2023 May; 77(4):367-378. PubMed ID: 36173202 [TBL] [Abstract][Full Text] [Related]
18. Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample. Jones G; Lipson J; Wang E Sci Rep; 2023 Feb; 13(1):2466. PubMed ID: 36774449 [TBL] [Abstract][Full Text] [Related]
19. Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom. Simonsson O; Osika W; Stenfors CUD; Goldberg SB; Honk L; Hendricks PS Psychol Med; 2024 Apr; 54(6):1228-1234. PubMed ID: 37859627 [TBL] [Abstract][Full Text] [Related]
20. Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery. VanderZwaag B; Garcia-Romeu A; Garcia-Barrera MA Ther Adv Psychopharmacol; 2024; 14():20451253241264812. PubMed ID: 39132012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]